Journal of Obesity and Overweight

Dr. Xu-Feng Huang is a Deputy Executive Director (Scientific) of the Illawarra Health and Medical Research Institute (IHMRI) at University of Wollongong in Australia. He is also a member of the Scientific Advisory Committee and Convener of the Developmental Neurobiology Panel of the Schizophrenia Research Institute. He was the Foundation Scientific Director (Metabolic Theme) at IHMRI and a member of the External Advisory Board of AstraZeneca Sweden. He has been involved in decision-making in high-level UOW committees, including Senate and the Gene Technology Regulatory Committee and Associate Head of the School of Health Sciences. He has served on the NHMRC Grant Review Panel and the ARC ERA Panel. He is currently an ARC Australian Reader. He is a grant assessor for nationally competitive grants, including ARC, NHMRC, and Diabetes Australia. He is an Editorial Board member of 3 international journals, and a reviewer for 13 international scholarly journals. His research interests are the neuropathology and neuropharmacology of severe mental disorders, body weight control, and type 2 diabetes. His multidisciplinary research experience includes neurobiology, nanotechnology, drug delivery, chemistry and clinical studies. His expertise lies in molecular neurobiology, receptor binding assays, beta imager analysis, animal models, cell culture, immunohistochemistry and histopathology.